10月30日，Hims & Hers Health Inc.盘中下跌5.09%，报28.07美元/股，成交额4296.15万美元。
消息面上，市场仍在消化公司请求加州联邦法官驳回联邦贸易委员会投诉的进展。该投诉指称公司曾误导消费者购买产品，并对不需要的订阅收费，相关司法走向持续影响投资者情绪。
从基本面看，公司此前仍在推进扩张，包括在澳大利亚推出Hers女性健康平台，并拓展女性健康、体重管理等服务，但短期交易焦点更集中于监管与合规风险评估。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.